Aurora Cannabis (ACB) Short term Debt (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Short term Debt of $15.0 million for Q1 2025, down 61.42% year-on-year from $38.9 million in Q1 2024, and up 114.63% on a QoQ basis from $7.0 million in Q4 2024.
Aurora Cannabis (ACB) Short term Debt (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Short term Debt for 8 consecutive years, with $15.0 million the latest figure, recorded in Q1 2025.
- Quarterly Short term Debt fell 61.42% year-over-year to $15.0 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $15.0 million (down 61.42% YoY) and the FY2025 annual result came in at $15.5 million, down 60.17% from the prior year.
- Short term Debt grew to $15.0 million in Q1 2025 per ACB's latest filing, from $7.0 million in the prior quarter.
- Over the last five years, Short term Debt for ACB reached as high as $38.9 million in Q1 2024 and fell as low as $177632.0 in Q1 2022.
- A 5-year average of $8.9 million and a median of $7.7 million in 2023 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2021 — Short term Debt tumbled 98.51% — and 2022, when it soared 7666.4%.
- Year by year, Short term Debt stood at $180087.3 in 2021, then surged by 7666.4% to $14.0 million in 2022, then sank by 40.9% to $8.3 million in 2023, then declined by 15.49% to $7.0 million in 2024, then surged by 114.63% to $15.0 million in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $15.0 million, $7.0 million, and $38.9 million for Q1 2025, Q4 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14.99 Mn |
| Dec 31, 2024 | 6.99 Mn |
| Mar 31, 2024 | 38.86 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 10.30 Mn |
| Jun 30, 2023 | 7.71 Mn |
| Mar 31, 2023 | 7.08 Mn |
| Dec 31, 2022 | 13.99 Mn |
| Sep 30, 2022 | 13.40 Mn |
| Jun 30, 2022 | 11.27 Mn |
| Mar 31, 2022 | 177,631.97 |
| Dec 31, 2021 | 180,087.29 |
| Sep 30, 2021 | 299,492.31 |
| Jun 30, 2021 | 304,259.16 |
| Mar 31, 2021 | 202,265.38 |
| Dec 31, 2020 | 196,365.99 |
| Sep 30, 2020 | 216,122.02 |
| Jun 30, 2020 | 13.74 Mn |
| Mar 31, 2020 | 13.55 Mn |
| Dec 31, 2019 | 18.66 Mn |